200 related articles for article (PubMed ID: 28850063)
1. Most Do, but Some Do Not: CD4⁺CD25
Hombach AA; Abken H
Cancers (Basel); 2017 Aug; 9(9):. PubMed ID: 28850063
[TBL] [Abstract][Full Text] [Related]
2. CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation.
Kofler DM; Chmielewski M; Rappl G; Hombach A; Riet T; Schmidt A; Hombach AA; Wendtner CM; Abken H
Mol Ther; 2011 Apr; 19(4):760-7. PubMed ID: 21326215
[TBL] [Abstract][Full Text] [Related]
3. CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack.
Chmielewski M; Hombach AA; Abken H
Gene Ther; 2011 Jan; 18(1):62-72. PubMed ID: 20944680
[TBL] [Abstract][Full Text] [Related]
4. Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor.
Hombach A; Köhler H; Rappl G; Abken H
J Immunol; 2006 Oct; 177(8):5668-75. PubMed ID: 17015756
[TBL] [Abstract][Full Text] [Related]
5. OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.
Hombach AA; Heiders J; Foppe M; Chmielewski M; Abken H
Oncoimmunology; 2012 Jul; 1(4):458-466. PubMed ID: 22754764
[TBL] [Abstract][Full Text] [Related]
6. GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD
Glienke W; Dragon AC; Zimmermann K; Martyniszyn-Eiben A; Mertens M; Abken H; Rossig C; Altvater B; Aleksandrova K; Arseniev L; Kloth C; Stamopoulou A; Moritz T; Lode HN; Siebert N; Blasczyk R; Goudeva L; Schambach A; Köhl U; Eiz-Vesper B; Esser R
Front Immunol; 2022; 13():839783. PubMed ID: 35401506
[TBL] [Abstract][Full Text] [Related]
7. Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling.
Hombach AA; Abken H
Int J Cancer; 2011 Dec; 129(12):2935-44. PubMed ID: 22030616
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
9. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.
Wu J; Yi S; Ouyang L; Jimenez E; Simond D; Wang W; Wang Y; Hawthorne WJ; O'Connell PJ
Transplantation; 2008 Jun; 85(12):1841-8. PubMed ID: 18580479
[TBL] [Abstract][Full Text] [Related]
10. Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor.
Henderson MA; Yong CS; Duong CP; Davenport AJ; John LB; Devaud C; Neeson P; Westwood JA; Darcy PK; Kershaw MH
Immunotherapy; 2013 Jun; 5(6):577-90. PubMed ID: 23725282
[TBL] [Abstract][Full Text] [Related]
11. Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.
Watanabe K; Terakura S; Martens AC; van Meerten T; Uchiyama S; Imai M; Sakemura R; Goto T; Hanajiri R; Imahashi N; Shimada K; Tomita A; Kiyoi H; Nishida T; Naoe T; Murata M
J Immunol; 2015 Feb; 194(3):911-20. PubMed ID: 25520398
[TBL] [Abstract][Full Text] [Related]
12. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor CC49-zeta CD4 T cells possess both cytolytic and helper functions.
Patel SD; Ge Y; Moskalenko M; McArthur JG
J Immunother; 2000; 23(6):661-8. PubMed ID: 11186154
[TBL] [Abstract][Full Text] [Related]
14. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
Koehler H; Kofler D; Hombach A; Abken H
Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
[TBL] [Abstract][Full Text] [Related]
15. The weal and woe of costimulation in the adoptive therapy of cancer with chimeric antigen receptor (CAR)-redirected T cells.
Hombach AA; Holzinger A; Abken H
Curr Mol Med; 2013 Aug; 13(7):1079-88. PubMed ID: 23116267
[TBL] [Abstract][Full Text] [Related]
16. CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop.
Golumba-Nagy V; Kuehle J; Hombach AA; Abken H
Mol Ther; 2018 Sep; 26(9):2218-2230. PubMed ID: 30055872
[TBL] [Abstract][Full Text] [Related]
17. T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.
D'Aloia MM; Caratelli S; Palumbo C; Battella S; Arriga R; Lauro D; Palmieri G; Sconocchia G; Alimandi M
Cytotherapy; 2016 Feb; 18(2):278-90. PubMed ID: 26705740
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma.
Skuljec J; Chmielewski M; Happle C; Habener A; Busse M; Abken H; Hansen G
Front Immunol; 2017; 8():1125. PubMed ID: 28955341
[TBL] [Abstract][Full Text] [Related]
19. Effect of Salmonella infection on cecal tonsil regulatory T cell properties in chickens.
Shanmugasundaram R; Kogut MH; Arsenault RJ; Swaggerty CL; Cole K; Reddish JM; Selvaraj RK
Poult Sci; 2015 Aug; 94(8):1828-35. PubMed ID: 26049799
[TBL] [Abstract][Full Text] [Related]
20. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]